A nutrient pharmaceutical formulation composition useful for treating cancer
comprising
ascorbic acid, L-lysine, L-proline and at least one polyphenol compound selected
from the group consisting of epigallocatechin gallate, epicatechin gallate, epigallocatechin,
epicatechin, catechin and the use of the composition in treating cancer and other
tumors are provided.